DRI opiate reagent kits
Ended Awarded Last action
- Contract number
- W81K0426FA042
- Awardee
-
Microgenics Corporation UEI E7WGWEK19Y79
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $8,135
Award facts
- Contract value 100% obligated
- $8,134.80 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Meade, MD 20755, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a delivery order valued at $8,134.80 to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, for DRI opiate reagent kits to be delivered to Fort Meade, Maryland. The contract, effective June 1, 2025, with an ultimate completion date of May 31, 2028, is structured as a firm fixed-price delivery order with no set-aside designation. Microgenics, headquartered in Fremont, California, is a specialized manufacturer of clinical diagnostic products and immunoassay reagent test kits used primarily for substance detection and medical screening in healthcare settings.
This delivery order supports the Department of Defense Drug Demand Reduction Program and falls under Microgenics' existing framework of federal healthcare diagnostics contracts. The company has established itself as a key supplier of toxicology testing reagents to military and veterans healthcare systems, holding multiple significant indefinite delivery contracts for various drug detection kits including benzodiazepine, MDMA/MDA, amphetamine, methamphetamine, hydrocodone, and opiate reagent products. These contracts are primarily awarded through the Navy Bureau of Medicine and Surgery, Defense Health Agency, and Veterans Affairs agencies, reflecting Microgenics' competitive standing in the federal marketplace for substance abuse testing and clinical diagnostic supplies.
Quick answers
Who was awarded contract W81K0426FA042?
W81K0426FA042 was awarded to Microgenics Corporation by Medical Command (Department of the Army) on June 1, 2025.
How much is contract W81K0426FA042 worth?
The government has obligated $8,135 on W81K0426FA042.
Which agency awarded contract W81K0426FA042?
Medical Command (Department of the Army) awarded W81K0426FA042, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0426FA042 an order under another contract?
Yes. W81K0426FA042 is a delivery order under N6264523D5006, an indefinite delivery contract.
Was contract W81K0426FA042 competed?
The extent of competition for W81K0426FA042 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award